[DOI] [PubMed] [Google Scholar] 145.Navaneethan S.D., Bansal N., Cavanaugh K.L., Chang A., Crowley S., Delgado C., Estrella M.M., Ghossein C., Ikizler T.A., Koncicki H., et al
345,346 GLP-1 may also reduce the expression of cartilage-degrading enzymes by inhibiting the MAPK pathway or activating anti-inflammatory pathways such as PI3K/Akt, thereby alleviating cartilage damage
As of 2024, retatrutide is not FDA approved
Storage Storage Store the lyophilized powder at room temperature, below 30 C
Both compounds share a fatty-acid conjugation strategy that extends plasma half-life via albumin binding, enabling once-weekly application in vivo models
In other words, the pathways plateau at different points, creating a scenario where more dosage drives further weight loss without proportionally increasing metabolic benefit